FDA-Inspected Site

Tokyo Boeki Medisys, Inc.

2 FDA inspections are on record for Tokyo Boeki Medisys, Inc. in Hino, Japan.

483· Form 483 issued

Hino, Japan · Last updated July 9, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2017-03-24.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
21 Mar 2017 – 24 Mar 2017Medical Devices & Rad Health483View 483 →
24 Feb 2014 – 27 Feb 2014Medical Devices & Rad HealthClean

Observations on record

Form 483 observations cited at this site, most recent first.

24 Mar 2017
21 CFR 803.17(a)(1)

Lack of System for Event Evaluations

Cited by Catherine J Laufmann

24 Mar 2017
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Catherine J Laufmann

24 Mar 2017
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Catherine J Laufmann

24 Mar 2017
21 CFR 820.250(b)

Sampling methods - Lack of or inadequate procedures

Cited by Catherine J Laufmann

24 Mar 2017
21 CFR 820.30(f)

Design verification - documentation

Cited by Catherine J Laufmann

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 803.17(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.250(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(f)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Tokyo Boeki Medisys, Inc.'s 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat